Synthesis and MEK1 inhibitory activities of imido-substituted 2-chloro-1,4-naphthoquinones

被引:32
作者
Bakare, O
Ashendel, CL
Peng, HR
Zalkow, LH
Burgess, EM
机构
[1] Howard Univ, Dept Chem, Washington, DC 20059 USA
[2] Purdue Univ, Sch Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
[3] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0968-0896(03)00267-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitogen activated protein kinases are of interest as research tools and as therapeutic target for certain physiological disorders. In this study, we found 2-chloro-3-(N-succinimidyl)-1,4-naphthoquinone 6 to be a selective inhibitor of MEK1 with an IC50 of 0.38 muM. An open-chain homologue, 10, showed selective cytotoxicity against renal cancer in the NCI in vitro tumor screeninQ. Structure-activity relationship study of eight compounds showed the cyclic imido-substituted chloro-1,4-naphthoquinone as more potent and selective MEK1 inhibitors than the open chain homologues. The imido-substituted chloro-1,4-naphthoquinones were synthesized in a straightforward fashion by refluxing 2-amino-3-chloro-1,4-naphthoquinone with the appropriate acid chloride or diacyl dichloride. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3165 / 3170
页数:6
相关论文
共 17 条
  • [1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [2] Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes
    Amundadottir, LT
    Leder, P
    [J]. ONCOGENE, 1998, 16 (06) : 737 - 746
  • [3] Design of antineoplastic agents based on the "2-phenylnaphthalene-type" structural pattern. 4. Synthesis and biological activity of 2-chloro-3-(substituted phenoxy)-1,4-naphthoquinones and related 5,8-dihydroxy-l,4-naphthoquinones
    Chang, HX
    Chou, TC
    Savaraj, N
    Liu, LF
    Yu, C
    Cheng, CC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (03) : 405 - 408
  • [4] HOW MAP KINASES ARE REGULATED
    COBB, MH
    GOLDSMITH, EJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) : 14843 - 14846
  • [5] Activation of raf-1 MEK, and MAP kinase in prolactin responsive mammary cells
    Das, R
    Vonderhaar, BK
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 40 (02) : 141 - 149
  • [6] 2-chloro-3-substituted-1,4-naphthoquinone inactivators of human cytomegalovirus protease
    Ertl, P
    Cooper, D
    Allen, G
    Slater, MJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (19) : 2863 - 2866
  • [7] Identification of a novel inhibitor of mitogen-activated protein kinase kinase
    Favata, MF
    Horiuchi, KY
    Manos, EJ
    Daulerio, AJ
    Stradley, DA
    Feeser, WS
    Van Dyk, DE
    Pitts, WJ
    Earl, RA
    Hobbs, F
    Copeland, RA
    Magolda, RL
    Scherle, PA
    Trzaskos, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 18623 - 18632
  • [8] Synthesis and antiplatelet, antiinflammatory, and antiallergic activities of substituted 3-chloro-5,8-dimethoxy-1,4-naphthoquinone and related compounds
    Huang, LJ
    Chang, FC
    Lee, KH
    Wang, JP
    Teng, CM
    Kuo, SC
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (12) : 2261 - 2269
  • [9] Kartoflitskaya A. P., 1997, PHARM CHEM J, V31, P291
  • [10] Synthesis and antiplatelet, antiinflammatory, and antiallergic activities of 2-substituted 3-chloro-1,4-naphthoquinone derivatives
    Lien, JC
    Huang, LJ
    Wang, JP
    Teng, CM
    Lee, KH
    Kuo, SC
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (12) : 2111 - 2120